ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 653 • 2016 ACR/ARHP Annual Meeting

    Thrombospondin-1 Is Highly Expressed By Salivary Gland Epithelial Cells of Sjögren’s Syndrome Patients, Both Constitutively and upon Exposure to Necrotic Cells Debris

    Aglaia G Vakrakou1,2, Markos D Patsouras1, Panagiotis G Vlachoyiannopoulos1, Athanasios G Tzioufas1 and Menelaos N Manoussakis2,3, 1Department of Pathophysiology, Department of Pathophysiology, School of Medicine, University of Athens, Greece, Athens, Greece, 2Hellenic Pasteur Institute, Athens, Greece., Hellenic Pasteur Institute, Athens, Greece, Athens, Greece, 3Department of Pathophysiology, School of Medicine, University of Athens, Greece, Department of Pathophysiology, School of Medicine, University of Athens, Greece, Athens, Greece

    Background/Purpose:  Sjögren’s syndrome (SS) patients manifest inflammation in salivary glands (SG) (lymphocytic infiltration of salivary and lachrymal glands) and evidence of intrinsic activation in the…
  • Abstract Number: 654 • 2016 ACR/ARHP Annual Meeting

    The Level of B-Cell Active Cytokines and Soluble B-Cell Activating Factor/a Proliferation-Inducing Ligand Receptors in Patients with Primary Sjogren’s Syndrome

    You Jung Ha1, Jaehyung Hur1, Sang Wan Chung1, Eun Ha Kang2, Yeong Wook Song3,4 and Yun Jong Lee5, 1Division of Rheumatology, Department of Internal Medicine, Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, The Republic of, 3WCU Department of Molecular Medicine and Biopharmaceutical Sciences, Medical Research Institute, WCU Department of Molecular Medicine and Biopharmaceutical Sciences, Medical Research Institute, Seoul National University College of Medicine, Seoul, Korea, The Republic of, 4Department of Internal Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, 5Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea

    Background/Purpose: Primary Sjögren`s syndrome (pSS) is an autoimmune diseases characterized by lymphocytic infiltration of exocrine glands and dysregulated proliferation and differentiation of B cells. Two…
  • Abstract Number: 655 • 2016 ACR/ARHP Annual Meeting

    Comprehensive Immuno-Phenotyping of Follicular Helper T Cells and B Cell Subpopulations in Primary Sjögren’s Syndrome

    Nida Meednu1, Cécile Seifert2, Jennifer Barnard3, Madhu Ramaswamy4, Jeffrey Riggs4, Alex Rosenberg3, Jamie Biear5, Gianluca Carlesso4, Ralf G. Thiele6, Andreea Coca3, Fanny Monneaux2, Helene Dumortier2, Jacques-Eric Gottenberg2,7 and Jennifer H. Anolik3, 1Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 2CNRS, Immunopathologie et Chimie Thérapeutique/Laboratory of Excellence Medalis, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France, 3University of Rochester Medical Center, Rochester, NY, 4MedImmune LLC, Gaithersburg, MD, 5Rheumatology, University of Rochester Medical Center, Rochester, NY, 6Medicine, University of Rochester Medical Center, Rochester, NY, 7Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France

    Background/Purpose: Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease characterized by immune cell infiltration in the salivary glands resulting in ocular and oral dryness.…
  • Abstract Number: 656 • 2016 ACR/ARHP Annual Meeting

    ERdj5 Function Is Involved in Inflammatory Manifestations of Sjögren’s Syndrome in the Salivary Glands

    Eirini Apostolou1, Petros Moustardas2, Takao Iwawaki3, Giannis Spyrou2 and Athanasios G. Tzioufas4, 1Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 2Clinical and Experimental Medicine, Division of Microbiology and Molecular Medicine, Linköping University, Linköping, Sweden, 3Life Science, Division of Cell Medicine, Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan, 4School of Medicine, Pathophysiology Department, National and Kapodistrian University of Athens, Athens, Greece

    Background/Purpose:  Sjögren’s syndrome is a chronic autoimmune disorder that affects mainly the exocrine glands. The initiation and causative agents are still unknown. Endoplasmic Reticulum (ER)…
  • Abstract Number: 657 • 2016 ACR/ARHP Annual Meeting

    Expression of Type-III Interferons (IFNλs) and Their Receptor in Sjögren’s Syndrome

    Eirini Apostolou1, Efstathia K. Kapsogeorgou2, Orsia D. Konsta1, Ioannis Giotakis3, Maria Ioanna Saridaki4, Evangelos Andreakos4 and Athanasios G. Tzioufas5, 1Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 2Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 32nd Otolaryngology, “Attikon” University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 4Immunology, Center for Clinical and Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece, 5School of Medicine, Pathophysiology Department, National and Kapodistrian University of Athens, Athens, Greece

    Background/Purpose:  Type-III IFNs or IFNλs(IFNλ1/IL29, IFNλ2/IL28A and IFNλ3/IL28B) consist a recently identified group of IFNs,initiallyimplicated inseveral human diseases, including cancer and autoimmunity. In this study,…
  • Abstract Number: 658 • 2016 ACR/ARHP Annual Meeting

    Decreased Expression of Ten Micro-RNAs in Plasmacytoid Dendritic Cells of Patients with Primary SS Indicates Dysregulation on Multiple Levels  

    Maarten R. Hillen1,2, Sofie L.M. Blokland1,2, Elena Chouri1,2, Aike A. Kruize1, Marzia Rossato1,2, Joel A.G. van Roon1,2 and Timothy R.D.J. Radstake1,2, 1Department of Rheumatology & Clinical Immunology, UMC Utrecht, Utrecht, Netherlands, 2Laboratory of Translational Immunology, UMC Utrecht, Utrecht, Netherlands

    Background/Purpose:  Plasmacytoid dendritic cells (pDCs) are indicated to be key players in the pathogenesis of primary Sjögren’s syndrome (pSS) and important producers of type-1 interferon…
  • Abstract Number: 659 • 2016 ACR/ARHP Annual Meeting

    Low Dose IL-2 Therapy Can Restore the Balance of Th17 and Treg Cells in Refractory Patients with Sjogren’s Syndrome

    Miao Miao1, Shengxiao Zhang1, Xiao-Qing Liu1, Xiaoyan Wu2, Chong Gao3 and Xiao-Feng Li2, 1The Second Hospital of Shanxi Medical University, Taiyuan, China, 2Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China, 3Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women’s Hospital/Children’s Hospital Boston, Harvard Medical School, Boston, MA, Cambridge, MA

    Background/Purpose: The therapy for sjogren’s syndrome (SS) focuses on biological agents, immune inhibitors and glucocorticoid which can’t correct the problem of unbalance of Th17 and…
  • Abstract Number: 660 • 2016 ACR/ARHP Annual Meeting

    Expression of the Chemokine Receptor CXCR5 Is Decreased in the Periphery of Patients with Primary Sjogren’s Syndrome

    Marie Wahren-Herlenius1, Lara Adnan Aqrawi1, Margarita Ivanchenko1, Albin Björk1, Jorge Ramírez1, Marika Kvarnström1, Janicke Cecilie Liaaen Jensen2 and Kathrine Skarstein3, 1Karolinska Institutet, Stockholm, Sweden, 2University of Oslo, Oslo, Norway, 3University of Bergen, Bergen, Norway

    Background/Purpose: CXCR5 is a chemokine receptor expressed on B and T cell subsets, which binds the CXCL13 ligand produced by follicular dendritic cells. It is…
  • Abstract Number: 661 • 2016 ACR/ARHP Annual Meeting

    Epitope Specificity and End-Organ Susceptibility Dictates Anti-Ro52 Mediated Salivary Gland Dysfunction

    Magdalena Sroka1, Indranil Biswas1, Brian Shepherd1, Dat C Truong2, Harini Bagavant1 and Umesh S Deshmukh1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2University of Oklahoma, Norman, OK

    Background/Purpose: Circulating autoantibodies reactive against Ro52 are detected in the sera of 70% of patients with Sjögren’s syndrome (SS), and their presence has been associated…
  • Abstract Number: 662 • 2016 ACR/ARHP Annual Meeting

    The Unusual Cross-Reactivity of Anti Muscarinic Receptor 3 Monclonal Antibodies Derived from Salivary Glands of Sjögren’s Syndrome Patients to Ro Peptides

    Syed M.S. Quadri1, Kristi A. Koelsch2, Biji T Kurien3, Valerie M Harris4 and R. Hal Scofield2, 1Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2U.S. Department of Veterans Affairs Medical Center, Oklahoma City, OK, 3Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Sjogrens syndrome (SS) is a chronic autoimmune inflammatory disease the characterisitic features of which includes hypofunction of exocrine glands leading to decrease in salivation…
  • Abstract Number: 663 • 2016 ACR/ARHP Annual Meeting

    Cytokine and Chemokine Levels in Serum and Tears As Disease Activity Biomarkers in Patients with Primary Sjögren´s Syndrome

    Angel Alejandro Castillo-Ortiz1, Rosa Elda Barbosa-Cobos2, Lizbeth Becerril-Mendoza3, Gustavo Lugo-Zamudio4, Virgilio Lima-Gómez4, Adan Moreno-Eutimio5, Nayeli Nieto-Velázquez5 and Angel Tzec-Pérez5, 1Rheumatology, Hospital Juárez de México, Mérida, Mexico, 2Rheumatology, Hospital Juárez de México, Mexico, Mexico, 3Hospital Juárez de México, Mexico, Mexico, 4Hospital Juárez de México, México city, Mexico, 5Hospital Juárez de México, Mexico city, Mexico

    Background/Purpose: Evidence suggests that levels of different cytokines in primary Sjögren´s syndrome (pSS) are associated with cell infiltration degree within lacrimal and salivary glands and…
  • Abstract Number: 664 • 2016 ACR/ARHP Annual Meeting

    Regulation of Interferon Signaling By a Calcium-Induced miRNA in Primary Human Salivary Gland Epithelial Cells

    Shyh-Ing Jang, NIDCR, NIH, Bethesda, MD

    Background/Purpose: Sjögren's syndrome (SS), an autoimmune disease that targets the salivary and lacrimal glands which causes dry eyes (xerophthalmia) and dry mouth (xerostomia) phenotypes. In…
  • Abstract Number: 665 • 2016 ACR/ARHP Annual Meeting

    Salivary Gland Secretome: A Novel Tool to Identify Biomarkers of Dryness and Immunopathology in Primary Sjogren’s Syndrome and Non-Autoimmune Sicca Patients

    Sofie L.M. Blokland1,2, Maarten R. Hillen1,2, Aike A. Kruize3, Timothy R.D.J. Radstake1,2 and Joel A.G. van Roon1,2, 1Laboratory of Translational Immunology, UMC Utrecht, Utrecht, Netherlands, 2Department of Rheumatology & Clinical Immunology, UMC Utrecht, Utrecht, Netherlands, 3Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose: Salivary gland biopsy is essential in primary Sjögren’s syndrome (pSS) diagnostics. However, tissue analysis using the traditional method has several limitations including inaccuracy of quantification of lymphocytic infiltration and poor correlation with dryness.…
  • Abstract Number: 666 • 2016 ACR/ARHP Annual Meeting

    Immunoglobulin N-Glycosylation Acquired By Somatic Hypermutation As a Potential Mechanism for Non-Specific B Cell Activation in Sjogren’s Syndrome

    Kristi A. Koelsch1,2,3, Joshua Cavett4,5, Jacen Maier-Moore6, Kenneth Smith5, Christopher Lessard4,7,8, Lida Radfar9, David M. Lewis10, Biji T Kurien1,4,5, Astrid Rasmussen7, Kathy Sivils5,8, Judith A. James4,7,8, A. Darise Farris7 and R. Hal Scofield1,7,11, 1U.S. Department of Veterans Affairs Medical Center, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Okalahoma City, OK, 3Endocrinology and Diabetes, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 5Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Dept. of Clinical Laboratory Science, University of Texas at El Paso, El Paso, TX, 7Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 8Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 9Oral Diagnosis and Radiology Department, University of Oklahoma College of Dentistry, Oklahoma City, OK, 10Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 11College of Medicine, Section of Endocrinology and Diabetes, University of Oklahoma Health Sciences Center, Oklahoma City, OK

    Background/Purpose: Sjögren’s syndrome (SS) is a systemic autoimmune disease characterized by lymphocytic infiltration of the salivary and lacrimal glands resulting in tissue destruction, pathological dry…
  • Abstract Number: 667 • 2016 ACR/ARHP Annual Meeting

    Cytokine and Chemokine Levels in Serum and Saliva As Disease Activity Biomarkers in Patients with Primary Sjögren’s Syndrome

    Angel Tzec-Pérez1, Rosa Elda Barbosa-Cobos2, Gustavo Esteban Lugo-Zamudio3 and Lizbeth Teresa Becerril-Mendoza2, 1Hospital Juárez de México, Mexico city, Mexico, 2Rheumatology, Hospital Juárez de México, Mexico, Mexico, 3Rheumatology, Hospital Juárez de México, México, Mexico

    Background/Purpose: Background Evidence suggests that levels of different cytokines in primary Sjögren's syndrome (pSS) are associated with cell infiltration degree within salivary and lacrimal glands…
  • « Previous Page
  • 1
  • …
  • 1641
  • 1642
  • 1643
  • 1644
  • 1645
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology